Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer

<div>Identification and prognostic significance of TNM stage in LS SCLC-resected patients. (a) The DFS (<i>n</i> = 119) and OS (<i>n</i> = 112) curves of LS SCLC-resected patients by TNM stage (I, II, and III). (b) The DFS (<i>n</i> = 119) and OS (<i>n</i> = 112) curves of LS SCLC-resected patients by T stage (T1 and T2). (c) The DFS (<i>n</i> = 119) and OS (<i>n</i> = 112) curves of LS SCLC-resected patients by TNM stage (N0, N1, and N2).</div>

International Journal of Clinical Practice

fig1

Figure 1

Figure 1: Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer 